Revolutionizing cell and gene therapy with digitalization: a panel discussion with industry leaders

Join us for an insightful panel discussion featuring leading experts from RoslinCT, Champalimaud Foundation, and RegenexBio as we explore the transformative role of digitalization in the field of cell and gene therapy (CGT). This webinar will delve into how digital technologies are reshaping the landscape of advanced therapeutics, offering a comprehensive view of the current and future state of the industry.

Panelists will share their unique perspectives on the challenges faced in integrating digital solutions into CGT processes, discussing strategies for overcoming obstacles, such as data management, regulatory compliance, and scalability. Through real-world examples and case studies, they will highlight key lessons learned from their experiences and how these insights can guide future innovations. The discussion will also explore digitalization's potential to enhance precision, efficiency, and accessibility in therapeutic development. Whether you are a professional in the field or simply interested in the intersection of technology and medicine, this webinar promises valuable insights into the digital evolution of CGT.

In this webinar, listeners can:

• Gain a deeper understanding of industry-wide challenges, trends, and vision surrounding digitalization in CGT manufacturing
• Learn how to effectively digitalize and scale up your CGT manufacturing capabilities
• Enhance your digitalization plans with actionable digitalization strategies and insights from experienced industry leaders

Caitlin Harrison

Associate Director Microbiology at Regenxbio, Inc

Caitlin Harrison is an experienced quality professional with over 12 years of experience, specializing in Quality Control Microbiology in the pharma industry. She has experience with implementation and validation of several different computer systems, focusing on development of MODA-EM® for the QC lab and integration with processing equipment and external monitoring systems for automatic data migration.

Rebecca Street-Howards

Head of Digital Operations at RoslinCT

Rebecca Street-Howards is Head of Digital Operations at RoslinCT. Even after 20 years at GSK in various roles across R&D and the supply chain, she remains motivated by the combination of science, technology, and engineering in the pharmaceutical industry to save lives. Her expertise lies in biopharmaceutical scale-up and launch, sterile manufacturing, and digitization, including designing and delivering one of the UK's first digital factories. This experience is now helping her address the challenge of industrializing Cell and Gene Therapy—magical, lifesaving medicines—with a focus on how to produce them more efficiently, at lower cost, and with global reach.

Kanchan Deshpande

Associate Director, Marketing at Lonza

Kanchan Deshpande is the Associate Director of Marketing at Lonza, a global leader in the pharma, Biotech, and specialty ingredients markets. With over 15 years of experience in life sciences industry, Kanchan is a dynamic marketing professional with a strong foundation in pharmaceutical Biotechnology. She is passionate about leveraging data-driven insights, and implementing innovative marketing solutions to enhance customer engagement & business outcomes. At Lonza, she is dedicated to advancing company’s mission by fostering strategic partnerships, and promoting the company’s MODA Informatics solutions, and services.

Watch now

SPEAKERS

Caitlin Harrison

Associate Director Microbiology at Regenxbio, Inc

Rebecca Street-Howards

Head of Digital Operations at RoslinCT

Kanchan Deshpande

Associate Director, Marketing at Lonza

You might also like

Revolutionizing upstream gene therapy manufacturing with nanofiber microcarriers

J Counsell, L Chirica, L Mellby

27 November

Watch

Trends in innovation for downstream process intensification, product yield, single-use closed systems, and gentle ATMP bioprocessing: a KOL panel discussing 2024 insights in gene therapy manufacturing

Rachel Legmann, Andrew Tustian

27 February

Watch

Preserving the future of medicine: standardizing leukapheresis materials with cryopreservation for scalable cell therapies

R Luke, M Giedlin, D Clarke et al.

12 December

Watch

Supporting efficacy and scaling with a next-generation T cell AOF formulation medium

Alan Gutowski, Joanna Kern

23 July

Watch